Kontigo Care (KONT) Q4 2025 earnings summary

Executive summary

• 2025 was a transition year with strategic changes, including a shift from R&D to a product-focused company and a new business model for longer, more predictable contracts.

• Demand was impacted by strained municipal finances, leading to longer sales cycles and lower license volumes.

• Five out of six public tenders were won, strengthening the position in the key municipal segment.

• Expansion outside the traditional municipal market progressed, with private sector and international projects showing potential.

Financial highlights

• Q4 2025 net sales were 7.6 MSEK, up 0.2% year-over-year; full-year net sales were 29.1 MSEK, down 3.7%.

• Q4 EBIT was -1.2 MSEK (EBIT margin -16.4%), impacted by -1.3 MSEK in one-time CEO transition costs; full-year EBIT was -2.1 MSEK (margin -7.3%).

• Q4 net result was -1.2 MSEK (-0.03 SEK/share); full-year net result was -2.1 MSEK (-0.06 SEK/share).

• Q4 free cash flow was 1.1 MSEK; full-year free cash flow was -3.2 MSEK, improved from -6.1 MSEK in 2024.

• Cash at year-end was 14.9 MSEK, with no outstanding loans.

Outlook and guidance

• Focus for 2026 is on increasing activation among existing customers, more platform agreements, and converting won tenders into revenue.

• No formal financial forecasts were provided.